Literature DB >> 19376223

Phosphatidylinostitol-3 kinase and phospholipase C enhance CSF-1-dependent macrophage survival by controlling glucose uptake.

Margaret Chang1, John A Hamilton, Glen M Scholz, Paul Masendycz, S Lance Macaulay, Caryn L Elsegood.   

Abstract

Colony stimulating factor-1 (CSF-1)-dependent macrophages play crucial roles in the development and progression of several pathological conditions including atherosclerosis and breast cancer metastasis. Macrophages in both of these pathologies take up increased amounts of glucose. Since we had previously shown that CSF-1 stimulates glucose uptake by macrophages, we have now investigated whether glucose metabolism is required for the survival of CSF-1-dependent macrophages as well as examined the mechanism by which CSF-1 stimulates glucose uptake. Importantly, we found that CSF-1-induced macrophage survival required metabolism of the glucose taken up in response to CSF-1 stimulation. Kinetic studies showed that CSF-1 stimulated an increase in the number of glucose transporters at the plasma membrane, including Glut1. The uptake of glucose induced by CSF-1 required intact PI3K and PLC signalling pathways, as well as the downstream effectors Akt and PKC, together with a dynamic actin cytoskeleton. Expression of constitutively active Akt partially restored glucose uptake and macrophage survival in the absence of CSF-1, suggesting that Akt is necessary but not sufficient for optimal glucose uptake and macrophage survival. Taken together, these results suggest that CSF-1 regulates macrophage survival, in part, by stimulating glucose uptake via Glut1, and PI3K and PLC signalling pathways.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19376223     DOI: 10.1016/j.cellsig.2009.04.003

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  14 in total

1.  Doxorubicin resistance mediated by cytoplasmic macrophage colony-stimulating factor is associated with switch from apoptosis to autophagic cell death in MCF-7 breast cancer cells.

Authors:  Mengxia Zhang; Hailiang Zhang; Fan Tang; Yuhua Wang; Zhongcheng Mo; Xiaoyong Lei; Shengsong Tang
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-24

2.  Activating transcription factor 4 regulates osteoclast differentiation in mice.

Authors:  Huiling Cao; Shibing Yu; Zhi Yao; Deborah L Galson; Yu Jiang; Xiaoyan Zhang; Jie Fan; Binfeng Lu; Youfei Guan; Min Luo; Yumei Lai; Yibei Zhu; Noriyoshi Kurihara; Kenneth Patrene; G David Roodman; Guozhi Xiao
Journal:  J Clin Invest       Date:  2010-07-12       Impact factor: 14.808

Review 3.  Diabetic vascular disease and the potential role of macrophage glucose metabolism.

Authors:  Tomohiro Nishizawa; Karin E Bornfeldt
Journal:  Ann Med       Date:  2011-06-17       Impact factor: 4.709

4.  Colony-Stimulating Factor 1 Receptor (CSF1R) Activates AKT/mTOR Signaling and Promotes T-Cell Lymphoma Viability.

Authors:  Carlos Murga-Zamalloa; Delphine C M Rolland; Avery Polk; Ashley Wolfe; Hiran Dewar; Pinki Chowdhury; Ozlem Onder; Rajan Dewar; Noah A Brown; Nathanael G Bailey; Kedar Inamdar; Megan S Lim; Kojo S J Elenitoba-Johnson; Ryan A Wilcox
Journal:  Clin Cancer Res       Date:  2019-10-21       Impact factor: 12.531

5.  Metabolic Reprogramming Mediated by the mTORC2-IRF4 Signaling Axis Is Essential for Macrophage Alternative Activation.

Authors:  Stanley Ching-Cheng Huang; Amber M Smith; Bart Everts; Marco Colonna; Erika L Pearce; Joel D Schilling; Edward J Pearce
Journal:  Immunity       Date:  2016-10-18       Impact factor: 31.745

6.  Targeting parvalbumin promotes M2 macrophage polarization and energy expenditure in mice.

Authors:  Shaojian Lin; Anke Zhang; Ling Yuan; Yufan Wang; Chuan Zhang; Junkun Jiang; Houshi Xu; Huiwen Yuan; Hui Yao; Qianying Zhang; Yong Zhang; Meiqing Lou; Ping Wang; Zhen-Ning Zhang; Bing Luan
Journal:  Nat Commun       Date:  2022-06-08       Impact factor: 17.694

7.  Metabolic reprogramming of macrophages: glucose transporter 1 (GLUT1)-mediated glucose metabolism drives a proinflammatory phenotype.

Authors:  Alex J Freemerman; Amy R Johnson; Gina N Sacks; J Justin Milner; Erin L Kirk; Melissa A Troester; Andrew N Macintyre; Pankuri Goraksha-Hicks; Jeffery C Rathmell; Liza Makowski
Journal:  J Biol Chem       Date:  2014-02-03       Impact factor: 5.157

Review 8.  CSF-1 receptor signaling in myeloid cells.

Authors:  E Richard Stanley; Violeta Chitu
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-06-02       Impact factor: 10.005

9.  Hypoxia enhances the proliferative response of macrophages to CSF-1 and their pro-survival response to TNF.

Authors:  John A Hamilton; Derek C Lacey; Amanda Turner; Bernard de Kok; Jennifer Huynh; Glen M Scholz
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

Review 10.  Can FDA-Approved Immunomodulatory Drugs be Repurposed/Repositioned to Alleviate Chronic Pain?

Authors:  Kufreobong E Inyang; Joseph K Folger; Geoffroy Laumet
Journal:  J Neuroimmune Pharmacol       Date:  2021-05-26       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.